Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma

Cancer Science(2024)10.1111/cas.16141Source: DataRank Database

Aberrant TIMP‐1 production in tumor‐associated fibroblasts drives the selective benefits of nintedanib in lung adenocarcinoma is a research paper published in Cancer Science (2024). On theSindex it has a DataRank of 0. It has been cited 5 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access5 citations

Download PDF

Cite:

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (21 grants)Impact (FWCI 0.90)OA: goldTopics (61)IDs (PubMed, PMC, OpenAlex)SDGs (2)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (16)

Natalia Díaz‐Valdivia ORCID,Marta Gabasa ORCID,Rafael Ikemori ORCID,Marselina Arshakyan ORCID,Patricia Fernández‐Nogueira ORCID

Live enrichment

PubMed:38476010 PMC:PMC11093210 OpenAlex:https://openalex.org/W4392742471

Sociedad Española de Neumología y Cirugía Torácica

Grant: SEPAR 437

Universitat de València

Grant: UV‐INV‐AE‐1956876

Campus Ciències de la Salut de Bellvitge, Universitat de Barcelona

Grant: Fellowship to Paula Duch

National Institutes of Health

Grant: R01 HL157424

Ciência sem Fronteiras

Grant: Fellowship to Rafael Ikemori

Fundación Científica Asociación Española Contra el Cáncer

Grant: AECC B16‐917

Comisión Nacional de Investigación Científica y Tecnológica

Grant: fellowship to Natalia Díaz‐Valdivia